Optimizing psychedelic compounds for neuropsychiatric therapy

Neuropsychopharmacology. 2021 Jul;46(8):1397-1398. doi: 10.1038/s41386-021-01004-7. Epub 2021 Apr 5.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Hallucinogens* / therapeutic use
  • Lysergic Acid Diethylamide
  • Psilocybin

Substances

  • Hallucinogens
  • Psilocybin
  • Lysergic Acid Diethylamide